Clearside Biomedical
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Clearside Biomedical's past years’ income statements indicate that its last revenue has increased compared to the previous period by 520% to $8,226,000. The net income raised on -$32,485,000 and profit margin reached -395%. Total operating expenses were $32,715,000.

Profit Margin

Clearside Biomedical, Inc. (NASDAQ:CLSD): Profit margin
2014 0 -10.18M
2015 0 -17.63M
2016 520K -25.88M -4977.31%
2017 345K -58.97M -17094.2%
2018 30K -82.81M -276060%
2019 2.17M -30.55M -1406.3%
2020 7.89M -18.03M -228.4%
2021 29.57M 376K 1.27%
2022 1.32M -34.07M -2567.55%
2023 8.22M -32.48M -394.91%

CLSD Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
8.22M1.32M29.57M7.89M2.17M30K345K520K00
Cost of revenue
355K204K178K0000033K0
Gross profit
7.87M1.12M29.39M7.89M2.17M30K345K520K-33K0
Operating exp.
Research and development
20.84M19.63M18.53M15.07M15.65M68.29M49.05M19.45M10.76M6.69M
Selling and marketing
0000000000
Total operating expenses
32.71M31.4M30.20M25.82M32.47M82.97M58.75M25.71M17.31M9.82M
Operating income
-24.84M-30.27M-627K-17.93M-30.30M-82.94M-58.40M-25.19M-17.31M-9.82M
Other income (expenses), net
-7.64M-2.67M1.00M-275K-466K127K-567K-684K-322K-366K
Income before tax
-32.48M-32.94M376K-18.21M-30.77M-82.81M-58.97M-25.88M-17.63M-10.18M
Income tax expense
01.12M0-180K-211K127K-182K-65K8K5K
Net income
-32.48M-34.07M376K-18.03M-30.55M-82.81M-58.97M-25.88M-17.63M-10.18M
Earnings per share
Basic EPS
-0.53-0.570.00-0.39-0.8-2.69-2.33-1.97-1.44-0.83
Diluted EPS
-0.53-0.570.00-0.39-0.8-2.69-2.33-1.97-1.44-0.83
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData source